Product Information
RISPERIDONE ER 50 MG VIAL is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $812.3827 per EA under NDC 00480145308. Its NADAC has been published 115 times since Apr 17, 2024.
The High Outlier badge above means this manufacturer's average price in the Risperidone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480145308
Classification
Generic
Dosage Form
KIT
Last Updated
6/17/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA214068On Market Since
12/11/2023
Price Statistics
The NADAC for RISPERIDONE ER 50 MG VIAL has been published 115 times since Apr 17, 2024, and over the history we have for it it has declined 17.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $812.3827 per EA |
|---|---|
| All-time high | $989.6980 (May 15, 2024) |
| All-time low | $812.3827 (Jun 17, 2026) |
| 52-week high | $951.7423 |
| 52-week low | $812.3827 |
| Median price | $957.5992 |
| Average price | $950.1638 |
| Largest weekly change | -6.2% (Jun 17, 2026) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 54% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RISPERIDONE ER 50 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for RISPERIDONE ER 50 MG VIAL, manufactured by Teva Pharmaceuticals USA Inc., is $812.3827 per EA (NDC 00480145308), effective Jun 24, 2026.
How has the price of RISPERIDONE ER 50 MG VIAL changed over time?
Over the history we have for it, the NADAC for RISPERIDONE ER 50 MG VIAL has declined 17.9%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for RISPERIDONE ER 50 MG VIAL?
Since Apr 17, 2024, the NADAC for RISPERIDONE ER 50 MG VIAL has ranged from a low of $812.3827 (Jun 17, 2026) to a high of $989.6980 (May 15, 2024), with a median of $957.5992 per EA.
Are there cheaper alternatives to RISPERIDONE ER 50 MG VIAL?
Yes. 2 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RISPERIDONE ER 25 MG VIAL, is $369.6407 per EA — about 54% below RISPERIDONE ER 50 MG VIAL.
Who manufactures RISPERIDONE ER 50 MG VIAL?
RISPERIDONE ER 50 MG VIAL (NDC 00480145308) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification